<i>PPM1D</i> Is a Therapeutic Target in Childhood Neural Tumors
Childhood medulloblastoma and high-risk neuroblastoma frequently present with segmental gain of chromosome 17q corresponding to aggressive tumors and poor patient prognosis. Located within the 17q-gained chromosomal segments is <i>PPM1D</i> at chromosome 17q23.2. <i>PPM1D</i>...
Main Authors: | Jelena Milosevic, Diana Treis, Susanne Fransson, Gabriel Gallo-Oller, Baldur Sveinbjörnsson, Nina Eissler, Keiji Tanino, Kazuyasu Sakaguchi, Tommy Martinsson, Malin Wickström, Per Kogner, John Inge Johnsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/23/6042 |
Similar Items
-
High Expression of <i>PPM1D</i> Induces Tumors Phenotypically Similar to <i>TP53</i> Loss-of-Function Mutations in Mice
by: Jelena Milosevic, et al.
Published: (2021-10-01) -
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline <i>ALK</i> F1174I Mutation
by: Anna Djos, et al.
Published: (2022-09-01) -
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro
by: Conny Tümmler, et al.
Published: (2019-02-01) -
Tipping Growth Inhibition into Apoptosis by Combining Treatment with MDM2 and WIP1 Inhibitors in p53<sup>WT</sup> Uterine Leiomyosarcoma
by: Victoria Chamberlain, et al.
Published: (2021-12-01) -
Optical Sensor for Diverse Organic Vapors at ppm Concentration Ranges
by: Dora M. Paolucci, et al.
Published: (2011-03-01)